[Diprophen therapy of patients with endarteritis obliterans in polyclinical conditions].
D004692:Endarteritis; D006801:Humans; D010276:Parasympatholytics / Q000628:therapy*; D010648:Phenylacetates / Q000628:therapy*; D013919:Thromboangiitis Obliterans / Q000628:therapy*
D010276:Parasympatholytics; D010648:Phenylacetates
PARASYMPATHOLYTICS/therapy; PHENYLACETATES/therapy; THROMBOANGIITIS OBLITERANS/therapy